In the rapidly evolving healthcare landscape, the concept of 4P Medicine—Prevention, Prediction, Precision, and Participation—marks a transformative shift towards personalized healthcare. This approach, refined over the last 15 years, aims to revolutionize how we understand, prevent, and treat diseases by focusing on each patient’s unique needs. The recent whitepaper by Worldwide Clinical Trials highlights the profound impact of 4P Medicine on clinical development and patient care.
Valneva gets approval for Chikungunya vaccine in Canada
Latest NewsValneva announces Health Canada approval of the world’s first chikungunya vaccine, IXCHIQ®.
Tubulis from Munich doses first Patient with own ADC linker technology
Latest NewsTubulis doses first patient in phase 1/2a trial investigating ADC candidate TUB-040 in ovarian cancer and lung adenocarcinoma (NSCLC). TUB-040 is a NaPi2b-targeting Exatecan ADC based on Tubulis’ proprietary linker technology with better biophysical properties that demonstrated effective and durable responses in a range of preclinical models.
BIOSECURE Act could affect half of US biopharmaceutical development
Latest NewsThe BIOSECURE Act of the United States could affect more than 120 US biopharmaceutical drugs partnered with Chinese companies ‘of concern’, as named in the bill. Of these, approximately half are in clinical trials (phases I to III) and a third are in early preclinical and discovery stages, according to GlobalData, the analytics company.
Macomics expands leadership team
AppointmentsA new Chief Business Officer strengthens the management team of Macomics Ltd (UK). Simon Drew took over the newly created position in June.
Danone, Michelin and DMC Biotechnologies open new cooperative fermentation site
Latest NewsFrench dairy giant Danone, engineering materials group Michelin, US start-up DMC Biotechnologies and Crédit Agricole Centre France have joined forces to create the Biotech Open Platform as precision fermentation centre.
Researchers identify blockers of CNS effects of PD1 cancer therapy
Latest NewsGerman researchers have tracked down the causes for central nervous system side effects of cancer immunotherapies and blocked them in small animal models.
The Power of 4P Medicine in Revolutionizing Patient Care
Sponsored PublicationsIn the rapidly evolving healthcare landscape, the concept of 4P Medicine—Prevention, Prediction, Precision, and Participation—marks a transformative shift towards personalized healthcare. This approach, refined over the last 15 years, aims to revolutionize how we understand, prevent, and treat diseases by focusing on each patient’s unique needs. The recent whitepaper by Worldwide Clinical Trials highlights the profound impact of 4P Medicine on clinical development and patient care.
CATALYSER – the Start-up-Magazine 2/24
ProductsA print magazine focussing on start-ups in the life sciences! Like a catalyst, it aims to promote young companies in the life sciences with the right impulses.
Evotec SE cashes in €20m milestone
Latest NewsEvotec SE has reached a predefined milestone worth €20m in the CRO’s partnership with Bristol Myers Squibb (BMS).
Tacalyx’ extends seed capital financing
Latest NewsGlycan target specialist Tacalyx GmbH expands its seed financing to €14m to advance its anti-TACA cancer therapies.